Drug Profile
Research programme: therapeutics - HUYA Bioscience/Tianjin Research Center of Basic Medical Sciences
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator HUYA Bioscience International; Tianjin Research Center of Basic Medical Science
- Developer HUYA Bioscience International
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Undefined in China
- 20 Aug 2012 Early research in Undefined indication in China (unspecified route)